News

 

 

May 24, 2019

Adecto Pharma awarded Phase I NCI SBIR grant for development of ADAM8 cancer diagnostic

October 22, 2018

Adecto Pharmaceuticals awarded multimillion-dollar NCI SBIR grant to continue development of ADAM8 targeted therapy

March 01, 2018

Adecto Pharmaceuticals selected to participate in MassBio’s MassCONNECT mentoring program

April 02, 2017

Adecto Pharmaceuticals presents poster on selection of lead candidate therapeutic antibodies at the 2017 AACR annual meeting

April 15, 2016

Adecto Pharmaceuticals awarded Phase I NCI STTR grant for the development of ADAM8 targeted therapies

April 13, 2015

Adecto Pharmaceuticals wins Tufts $100K New Ventures Competition

March 18, 2014

New Hope for Tough-to-Treat Breast Cancers

​Tufts researchers find promising target in battle against aggressive tumors  

Please reload